通过亚型来定义心脏粉样性结局的回声心脏学预测因子
Cristiane Singulane1, Deyu Sun1, Zhen Hu1
1University of Chicago, Department of Medicine, Section of Cardiology, Chicago, IL, USA.
Current problems in cardiology
|June 30, 2024
概括
心脏 Amyloidosis 的预后因素因亚型而异. 心声学揭示了transthyretin (TTR) 和轻链 (AL) 氨基粉症的明显生存预测因子,有助于个性化患者管理.
科学领域:
- 心脏病学 心脏病学
- 心血管成像 - 心血管成像
- 医学诊断 医学诊断 医学诊断
背景情况:
- 心脏 Amyloidosis (CA) 包含TTR和轻链AL亚型,每个亚型都需要不同的管理.
- 目前的心声回声预测器缺乏亚型特异性.
- 对于CA预后的先进回声心脏学技术还没有得到充分的研究.
研究的目的:
- 为了调查特定亚型的2D跨胸腔心声学 (2DE) 预测心脏粉样性病生存的预测因素.
- 确定高级心声回声学参数是否提供TTR-CA和AL-CA之间的差异性预后值.
主要方法:
- 一组220名确诊的CA患者 (AL=89,TTR=131) 在诊断时接受了全面的2DE.
- 评估的参数包括左心室和右心室尺寸,应变 (LVGLS,RVGLS),心房体积 (LAVi,RAVI) 和RV静脉压力 (RVSP).
- 一个因临床因素而调整的考克斯比例危险模型,在36个月的中位数随访期间确定了死亡率的预测因素.
主要成果:
- 右心室自由壁应变 (RVFWS) 和RV缩压 (RVSP) 预测了AL-CA的存活率.
- 在TTR-CA.中,上节约比率 (LVASR) 和右心房体积指数 (RAVi) 与存活率有关.
- 这些发现突出了每个CA亚型的独特的心声回声学预后特征.
结论:
- 生存的心声预测器是特定于心脏粉样蛋白亚型的.
- 这些亚型特定的发现可以为临床决策和患者随访策略提供信息.
- 使用先进的心声回声学可以完善心脏粉症的风险分层.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...


